Skip to main content

National Cancer Institute

Call for internal proposals: The National Cancer Institute Outstanding Investigator Award

Aug. 23, 2016—The National Cancer Institute has announced the Outstanding Investigator Award funding opportunity. The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for seven years to provide funding stability.

Read more


VICC researchers to study reasons for high breast cancer incidence and mortality rates among African-American women

Jul. 6, 2016—A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.

Read more


Investigators find clues to melanoma treatment resistance

Oct. 29, 2015—Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.

Read more


Strong scores put VICC among top NCI centers

Sep. 17, 2015—Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG).

Read more


Call for internal proposals: National Cancer Institute Outstanding Investigator Award

Sep. 11, 2015—Vanderbilt may submit more than one application to this program, provided each is scientifically distinct.

Read more


Macara lands award to explore cancer cell behavior

Aug. 13, 2015—Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.”

Read more


NCI’s national report shows cancer deaths on decline in U.S.

Apr. 2, 2015—The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011.

Read more


Photo: Cancer discoveries

Mar. 26, 2015—Louis Staudt, M.D., Ph.D., director of the National Cancer Institute (NCI) Center for Cancer Genomics and co-chief of the NCI’s Lymphoid Malignancies Branch, spoke about new lymphoma therapies at his recent Flexner Discovery Lecture.

Read more


National Cancer Institute’s Staudt set for Discovery Lecture

Mar. 12, 2015—Louis Staudt, M.D., Ph.D., a pioneer in gene expression profiling at the National Cancer Institute (NCI), will deliver the next Flexner Discovery Lecture on Thursday, March 19.

Read more


Call for proposals: National Cancer Institute Outstanding Investigator Award

Jul. 15, 2014—The National Cancer Institute (NCI) is pleased to announce the Outstanding Investigator Award (OIA). The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for seven years to provide funding stability. NCI anticipates making about 50 awards annually. Vanderbilt may submit more than one application to this program, provided each is scientifically distinct. The OIA will allow funded investigators the freedom to embark on long-term projects of unusual potential in cancer research; the opportunity to take greater risks and be more adventurous in their lines of inquiry; and sufficient time to develop new techniques. The applicant PD/PI...

Read more


National Cancer Institute director set for Discovery Lecture

Nov. 14, 2013—The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall.

Read more


Vaccination key to preventing HPV-related cancers

Feb. 28, 2013—Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute.

Read more


VIEW MORE EVENTS >